The report said GSK’s former head of vaccine development, Philip Dormitzer, who joined the company after working at ...
Pfizer stock slipped about 0.7% to $25.19 after The Wall Street Journal reported on an inquiry looking into the suggestion ...
Years after the biopharmaceutical industry stepped up to create COVID-19 vaccines as the virus spiraled into a global ...
Dr. Peter Marks, a veteran of the agency, wrote that undermining confidence in vaccines is irresponsible and a danger to ...
Pfizer (PFE) shares slipped on Wednesday after The Wall Street Journal reported that U.S. authorities are investigating ...
Robert F. Kennedy Jr. is set to significantly cut the size of HHS, reshaping the nation’s health agencies and closing ...
Explore more
With the market underpricing its earnings stability and future catalysts, Pfizer presents a compelling defensive investment ...
The United States led the world in developing the technology that beat the COVID-19 pandemic. Action from lawmakers may leave ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results